A randomised controlled trial evaluated the glucose-lowering efficacy of empagliflozin, an SGLT2 inhibitor, as an adjunctive treatment in patients with HNF1A-related maturity-onset diabetes of the young (HNF1A-MODY), a rare monogenic form of diabete...
Type 1 diabetes mellitus (T1D) is an autoimmune disease that leads to the destruction of insulin-producing pancreatic beta cells. Practically, management of T1D requires multiple daily insulin injections, insulin pump therapy, or the use of an autom...
Previous research has shown a relationship between weight gain around holiday seasons and seasonal variations in lifestyle behaviours and eating patterns. As glycaemic outcome is also to directly affected by the lifestyle behaviours and eating patte...
